SMSandra Macfarlane

Sandra Macfarlane

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sandra Macfarlane has a total of 78 co-authors. Here are the top co-authors by number of shared publications:

  • George T. Macfarlane

    University of Dundee Microbiology and Gut Biology Group, Level 6, Ninewells Hospital and Medical School, Dundee, United Kingdom

    14 shared publications
  • G. T. Macfarlane

    Microbiology and Gut Biology Group; University of Dundee; Ninewells Hospital Medical School; Dundee; UK

    6 shared publications
  • Bahram Bahrami

    Microbiology and Gut Biology Group, University of Dundee, Dundee, United Kingdom

    5 shared publications
  • Elizabeth Furrie

    Microbiology and Gut Biology Group, University of Dundee, Dundee, United Kingdom

    5 shared publications
  • Andrew J. McBain

    Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK

    3 shared publications
  • B. Bahrami

    Microbiology and Gut Biology Group; University of Dundee; Ninewells Hospital Medical School; Dundee; UK

    3 shared publications

Latest Publications

  • Antibiotic treatments and microbes in the gut

    by Sandra Macfarlane

    Summary: Antibiotic therapies are important in combating disease‐causing microorganisms and maintaining host health. It is widely accepted that exposure of the gut microbiota to antibiotics can lead to decreased susceptibility and the development of multi‐drug‐resistant disease‐causing organisms, which can be a major clinical problem. It is also important to consider that antibiotics not only target pathogenic bacteria in the gut, but also can have damaging effects on the ecology of commensal species. This can reduce intrinsic colonization resistance and contribute to problems with antibiotic resistance, including lateral transfer of resistance genes. Our knowledge of the impact of antibiotic treatment on the ecology of the normal microbiota has been increased by recent advances in molecular methods and use of in vitro model systems to investigate the impact of antibiotics on the biodiversity of gut populations and the spread of antibiotic resistance. These highlight the need for more detailed structural and functional information on the long‐term antibiotic‐associated alterations in the gut microbiome, and spread of antibiotic resistance genes. This will be crucial for the development of strategies, such as targeted therapeutics, probiotics, prebiotics and synbiotics, to prevent perturbations in the gut microbiota, the restoration of beneficial species and improvements in host health.


  • Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double-blind, placebo-controlled crossover study

    by S. Macfarlane, S. Cleary, B. Bahrami, N. Reynolds, G. T. Macfarlane

    Ageing can result in major changes in the composition and metabolic activities of bacterial populations in the large gut and an impaired immune system. To investigate the effects of synbiotic consumption on the colonic microbiota, immune function and health status in older people. A randomised, double-blind placebo-controlled, 4-week crossover study was carried out, involving 43 older volunteers, using a synbiotic comprising the probiotic Bifidobacterium longum and an inulin-based prebiotic Synergy 1 (SudZucker, Mannheim, Germany). Faecal and blood samples were collected, and clinical status scored at the start, and at 2- and 4-week intervals, with a 4-week washout between each feeding period. Faecal bacteria were determined by fluorescent in situ hybridisation. Short-chain fatty acid concentrations, cytokine production, bowel habit and a range of clinical parameters were measured. The synbiotic increased bifidobacterial numbers by 1.4 log units (P < 0.0001) and also increased members of the phyla Actinobacteria and Firmicutes (P = 0.0004, P < 0.0001). Proteobacteria were reduced by 1.0 log units (P < 0.0001). Synbiotic feeding was associated with increased butyrate production (P = 0.0399). The pro-inflammatory response was modified by the synbiotic, with significantly reduced pro-inflammatory cytokine TNF-α in peripheral blood after 2 and 4 weeks of synbiotic consumption (P = 0.02, P = 0.0406). The synbiotic had no effect on bowel habit or any clinical parameters. Short-term synbiotic use can be effective in improving the composition and metabolic activities of colonic bacterial communities and immune parameters in older people. This study was registered at clinicaltrials.gov as NCT01226212.


  • Effects of Antibiotics on Bacterial Species Composition and Metabolic Activities in Chemostats Containing Defined Populations of Human Gut Microorganisms

    by Dorothy F. Newton, Sandra Macfarlane, George T. Macfarlane

    The composition and metabolic activities of the human colonic microbiota are modulated by a number of external factors, including diet and antibiotic therapy. Changes in the structure and metabolism of the gut microbiota may have long-term consequences for host health. The large intestine harbors a complex microbial ecosystem comprising several hundreds of different bacterial species, which complicates investigations on intestinal physiology and ecology. To facilitate such studies, a highly simplified microbiota consisting of 14 anaerobic and facultatively anaerobic organisms (Bacteroides thetaiotaomicron,Bacteroides vulgatus,Bifidobacterium longum,Bifidobacterium infantis,Bifidobacterium pseudolongum,Bifidobacterium adolescentis,Clostridium butyricum,C. perfringens,C. bifermentans,C. innocuum,Escherichia coli,Enterococcus faecalis,Enterococcus faecium,Lactobacillus acidophilus) was used in this investigation. Ampicillin [9.2 μg (ml culture)−1] was added to two chemostats operated at different dilution rates (D; 0.10 h−1and 0.21 h−1), and metronidazole [76.9 μg (ml culture)−1] was added to a third vessel (D= 0.21 h−1). Perturbations in bacterial physiology and metabolism were sampled over a 48-h period.Lactobacillus acidophilusandC. bifermentanspopulations did not establish in the fermentors under the imposed growth conditions. Ampicillin resulted in substantial reductions in bacteroides andC. perfringenspopulations at both dilution rates. Metronidazole strongly affected bacteroides communities but had no effect on bifidobacterial communities. The bacteriostatic effect of ampicillin on bifidobacterial species was growth rate dependent. Several metabolic activities were affected by antibiotic addition, including fermentation product formation and enzyme synthesis. The growth of antibiotic-resistant bifidobacteria in the large bowel may enable them to occupy ecological niches left vacant after antibiotic administration, preventing colonization by pathogenic species.


  • Longitudinal Analyses of Gut Mucosal Microbiotas in Ulcerative Colitis in Relation to Patient Age and Disease Severity and Duration

    by Alemu Fite, Sandra Macfarlane, Elizabeth Furrie, Bahram Bahrami, John H. Cummings, Douglas T. Steinke, George T. Macfarlane

    Bacteria belonging to the normal colonic microbiota are associated with the etiology of ulcerative colitis (UC). Although several mucosal species have been implicated in the disease process, the organisms and mechanisms involved are unknown. The aim of this investigation was to characterize mucosal biofilm communities over time and to determine the relationship of these bacteria to patient age and disease severity and duration. Multiple rectal biopsy specimens were taken from 33 patients with active UC over a period of 1 year. Real-time PCR was used to quantify mucosal bacteria in UC patients compared to 18 noninflammatory bowel disease controls, and the relationship between indicators of disease severity and bacterial colonization was evaluated by linear regression analysis. Significant differences were detected in bacterial populations on the UC mucosa and in the control group, which varied over the study period. High clinical activity indices (CAI) and sigmoidoscopy scores (SS) were associated with enterobacteria, desulfovibrios, type E Clostridium perfringens , and Enterococcus faecalis , whereas the reverse was true for Clostridium butyricum , Ruminococcus albus , and Eubacterium rectale . Lactobacillus and bifidobacterium numbers were linked with low CAI. Only E. rectale and Clostridium clostridioforme had a high age dependence. These findings demonstrated that longitudinal variations in mucosal bacterial populations occur in UC and that bacterial community structure is related to disease severity.


  • Open Access

    Effect of a synbiotic on microbial community structure in a continuous culture model of the gastric microbiota in enteral nutrition patients

    by Aileen R. Smith, George T. Macfarlane, Nigel Reynolds, Graeme A. O'MAy, Bahram Bahrami, Sandra Macfarlane

    Patients with dysphagia require long-term nutritional support. This can be delivered by the enteral route via a percutaneous endoscopic gastrostomy (


  • Adherence and Cytokine Induction in Caco-2 Cells by Bacterial Populations from a Three-Stage Continuous-Culture Model of the Large Intestine

    by Bahram Bahrami, Matthew W. Child, Sandra Macfarlane, George T. Macfarlane

    Adherence of bacteria to epithelial cells is an important step in colonization and immune modulation in the large bowel. The aims of this study were to use a three-stage continuous-culture system (CCS) to investigate how environmental factors affect bacterial attachment to Caco-2 cells and modulation of cytokine expression by gut microorganisms, including a probioticBifidobacterium longumstrain, DD2004. The CCS simulated environmental conditions in the proximal large intestine (vessel 1 [V1]) and distal colon (V2 and V3) at two different system retention times (R) within the range of normal colonic transits (20 and 60 h). The model was inoculated with human fecal material, and fluorescencein situhybridization (FISH) was used to characterize microbial populations and to assess bacterial attachment to Caco-2 cells. Real-time quantitative PCR (qPCR) was employed to measure cytokine gene expression following challenge with bacteria from different components of the CCS in the presence and absence ofB. longum. At anRof 60 h, bacterial adherence increased from V1 to V3, but this trend was reversed at anRof 20 h. Atopobia were the predominant adherent organisms detected at both system retention times in each culture vessel. Modulation of transforming growth factor β1 (TGF-β1), interleukin 6 (IL-6), and IL-18 gene expression by CCS bacteria was marked at anRof 60 h, while at anRof 20 h, IL-4, IL-10, TGF-β2, IL-1α, and tumor necrosis factor alpha (TNF-α) were significantly affected. The addition ofB. longumaffected cytokine expression significantly at both retention times. This study demonstrates that environmental determinants regulate the adherence properties of intestinal bacteria and their abilities to regulate cytokine synthesis.


  • Microbiological and immunological effects of enteral feeding on the upper gastrointestinal tract

    by Aileen Robertson Smith, Sandra Macfarlane, Elizabeth Furrie, Shakil Ahmed, Bahram Bahrami, Nigel Reynolds, George Tennant Macfarlane

    Enteral feeding via a percutaneous endoscopic gastrostomy tube is required for nutritional support in patients with dysphagia. Enteral tube feeding bypasses the innate defence mechanisms in the upper gastrointestinal tract. This study examined the surface-associated microbial populations and immune response in the gastric and duodenal mucosae of eight enteral nutrition (EN) patients and ten controls. Real-time PCR and fluorescence in situ hybridization were employed to assess microbiota composition and mucosal pro-inflammatory cytokine expression. The results showed that EN patients had significantly higher levels of bacterial DNA in mucosal biopsies from the stomach and duodenum (Pα, IL-6 and tumour necrosis factor-α was significantly higher in gastric and small intestinal mucosae from patients fed normal diets in comparison with those receiving EN (P<0.05). These results indicate that EN can lead to significant bacterial overgrowth on upper gastrointestinal tract mucosae and a significantly diminished pro-inflammatory cytokine response.


  • Mucosal Biofilm Communities in the Human Intestinal Tract

    by Sandra Macfarlane, Bahram Bahrami, George T. Macfarlane


  • Induction of cytokine formation by human intestinal bacteria in gut epithelial cell lines

    by B. Bahrami, S. Macfarlane, G.T. Macfarlane

    To investigate the effects of human gut micro-organisms on cytokine production by human intestinal cell lines. Quantitative real-time PCR assays were developed to measure the production of pro-inflammatory (IL-1α, IL-6, IL-18 and TNFα) and anti-inflammatory (TGF-β1, TGF-β2, TGF-β3, IL-4 and IL-10) cytokines in HT-29 and Caco-2 cell lines. They were co-cultured with a range of mucosal bacteria isolated from ulcerative colitis patients, together with lactobacilli and bifidobacteria obtained from healthy people. HT-29 cells were also co-cultured with Campylobacter jejuni, enterotoxigenic Escherichia coli (ETEC), enteropathogenic E. coli and Salmonella typhimurium. The majority of commensal bacteria tested suppressed the expression of anti-inflammatory cytokine mRNA, increased IL-18, reduced IL-1α, and with the exception of nonpathogenic E. coli, reduced TNF-α. All overtly pathogenic species increased both pro-inflammatory and anti-inflammatory cytokine mRNA. Commensal and pathogenic species induced fundamentally different cytokine responses in human intestinal epithelial cell lines. Interactions between commensal bacteria tested in this study and the innate immune system were shown to be anti-inflammatory in nature, in contrast to the pathogenic organisms investigated. These data contribute towards our understanding of how potential probiotic species can be used to suppress the pro-inflammatory response in inflammatory bowel disease.


  • Clinical trial: the microbiological and immunological effects of synbiotic consumption – a randomized double‐blind placebo‐controlled study in active Crohn’s disease

    by H. Steed, G. T. Macfarlane, K. L. Blackett, B. Bahrami, N. Reynolds, S. V. Walsh, J. H. Cummings, S. Macfarlane

    Aliment Pharmacol Ther 2010; 32: 872–883Summary: Background  Crohn’s disease is an inflammatory illness in which the immune response against gut microorganisms is believed to drive an abnormal immune response. Consequently, modification of mucosal bacterial communities, and the immune effects they elicit, might be used to modify the disease state.Aim  To investigate the effects of synbiotic consumption on disease processes in patients with Crohn's disease.Methods  A randomized, double‐blind placebo‐controlled trial was conducted involving 35 patients with active Crohn's disease, using a synbiotic comprising Bifidobacterium longum and Synergy 1. Clinical status was scored and rectal biopsies were collected at the start, and at 3‐ and 6‐month intervals. Transcription levels of immune markers and mucosal bacterial 16S rRNA gene copy numbers were quantified using real‐time PCR.Results  Significant improvements in clinical outcomes occurred with synbiotic consumption, with reductions in both Crohn's disease activity indices (P = 0.020) and histological scores (P = 0.018). The synbiotic had little effect on mucosal IL‐18, INF‐γ and IL‐1β; however, significant reductions occurred in TNF‐α expression in synbiotic patients at 3 months (P = 0.041), although not at 6 months. Mucosal bifidobacteria proliferated in synbiotic patients.Conclusion  Synbiotic consumption was effective in improving clinical symptoms in patients with active Crohn's disease.